Outpatient parenteral antimicrobial therapy (OPAT) in patients with cystic fibrosis

BMC Infectious Diseases

Volumn 15, Issue 1, 2015, Pages

  Pedersen, Maya Graham ^a   Jensen Fangel, Søren ^a   Olesen, Hanne Vebert ^a   Tambe, San deep Prataprao ^a   Petersen, Eskild ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Complications; Home therapy; Intravenous; Peripheral venous line; PICC line; PORT A CATH

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ALLERGIC REACTION; ANAPHYLAXIS; ANTIMICROBIAL THERAPY; ARTICLE; BOLUS INJECTION; CATHETER COMPLICATION; CATHETER DISLOCATION; CATHETER INFECTION; CATHETER OCCLUSION; CATHETER REMOVAL; CATHETER THROMBOSIS; CHILD; CYSTIC FIBROSIS; FEVER; HUMAN; IMPLANTABLE PORT SYSTEM; INFECTIOUS COMPLICATION; INFUSION PUMP; INJECTION SITE PAIN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OUTPATIENT; PERIPHERAL VENOUS CATHETER; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; RASH; VOMITING; ADVERSE EFFECTS; AMBULATORY CARE; DENMARK; FEMALE; HOME INFUSION THERAPY; INTRAVENOUS DRUG ADMINISTRATION; MALE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; AMBULATORY CARE; ANTI-INFECTIVE AGENTS; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; DENMARK; FEMALE; HOME INFUSION THERAPY; HUMANS; INFUSIONS, INTRAVENOUS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); OUTPATIENTS; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84937789627     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-015-1019-4     Document Type: Article

References (11)

1. Heijerman H. Infection and inflammation in cystic fibrosis: a short review. J Cyst Fibros. 2005;4:3-5.
2. Yankaskas JR, Knowles MR, Boat TF. Cystic fibrosis in adults. Philadelphia: Lippincott-Raven Publishers; 1999.
3. Döring G, Flume P, Heijerman H, Elborn JS. Treatment of lung infection in patients with cystic fibrosis: current and future strategies. J Cyst Fibros. 2012;11:461-79.
4. Hammond LJ, Caldwell S, Campbell PW. Cystic fibrosis, intravenous antibiotics and home therapy. J Pediatr Health Care. 1991;5:24-30.
5. Tice AD, Rehm SJ, Dalovisio JR, Bradley JS, Martinelli LP, Graham DR, et al. Practice guidelines for outpatient parenteral. Clin Infect Dis. 2004;38:1651-72.
6. Fothergill JL, Walshaw MJ, Winstanley C. Transmissible strains of Pseudomonas aeruginosa in cystic fibrosis lung infections. Eur Respir J. 2012;40:227-38.
7. Cheung E, Baerlocher MO, Asch M, Myers A. Venous access. Can Fam Physician. 2009;55:494-6.
8. Lai KK. Safety of prolonging peripheral cannula and i.v. tubing use from 72hours to 96hours. Am J Infect Control. 1998;26:66-70.
9. Tolomeo C, Mackey W. Peripherally inserted central catheters (PICCs) in the CF population: one center's experience. Pediatr Nurs. 2003;29:355-9.
10. Munck A, Malbezin S, Bloch J, Gerardin M, Lebourgeois M, Derelle J, et al. Follow-up of 452 totally implantable vascular devices in cystic fibrosis patients. Eur Respir J. 2004;23:430-4.
11. Hammond LJ. The Port-A-Cath and Per-Q-Cath. J Pediatr Health Care. 1991;5:31-3.